Testing a smartphone app to support women with gestational diabetes
Tests the MyGlucoCare app in pregnant women with gestational diabetes.
Key facts
- Who runs it
- Hong Kong Metropolitan University
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 May 2026
- Expected to end
- 30 Nov 2026
- Type of study
- Interventional
- Treatments tested
- MyGlucoCare
- Record updated
- 22 May 2026
Who can take part
The trial is looking for pregnant women with diabetes that started in pregnancy (gestational diabetes). They will use the "MyGlucoCare" smartphone app for 8-12 weeks.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Gestational diabetes found by a 75g glucose tolerance test done between 24 and 28 weeks of pregnancy.
- Earlier treatment
- People already in another structured self-care program for gestational diabetes cannot join.
- Biomarker or test result
- Gestational diabetes shown by a 75g Oral Glucose Tolerance Test (OGTT).
- Main reasons for not taking part
- Type 1 or Type 2 diabetes diagnosed before
- A known major problem in the baby's development
- Taking part in another structured self-care program for gestational diabetes
- Severe mental health conditions
- No smartphone with reliable internet, or unable to read and understand Chinese
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women diagnosed with Gestational Diabetes Mellitus (GDM) via a 75g Oral Glucose Tolerance Test (OGTT), conducted between 24 and 28 weeks of gestation (Hong Kong College of Obstetricians and Gynaecologists, 2016).
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Pregnant women diagnosed with Gestational Diabetes Mellitus (GDM) via a 75g Oral Glucose Tolerance Test (OGTT), conducted between 24 and 28 weeks of gestation (Hong Kong College of Obstetricians and Gynaecologists, 2016)
- Aged 18 years or older
- Own a smartphone with reliable internet access
- Able to read and understand Chinese
Who cannot take part
- Concurrent enrollment in any other structured GDM self-management intervention
- Pre-existing diagnosis of Type 1 or Type 2 diabetes mellitus
- Severe mental health conditions
- Known major fetal anomaly
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes mellitus
This trial is currently available in Hong Kong.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this pilot study is to test the feasibility and preliminary impact of "MyGlucoCare," a smartphone-based program designed to support women with gestational diabetes (GDM). The main questions it aims to answer are:
Read full original descriptionShow less
Is the "MyGlucoCare" program practical and acceptable for participants?
Does it show preliminary signs of improving self-management, blood sugar control, and well-being in women with gestational diabetes (GDM)?
Researchers will conduct a single-arm study to gather initial data on the program's use and effects, which will be used to plan a larger future clinical trial.
Participants will:
Use the "MyGlucoCare" app for 8-12 weeks during their pregnancy.
Receive personalized education, support from a clinician, and access to a moderated peer group through the app.
Complete questionnaires and log health data via the app at the start, near the end of pregnancy, and after giving birth.
Some participants will also take part in an interview to share their feedback on the program.
The group in the trial
- "MyGlucoCare" interventionTreatment being tested
The "MyGlucoCare" intervention is a comprehensive, technology-facilitated program delivered over 8 to 12 weeks.
Treatment: MyGlucoCare
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development and Feasibility Testing of the "MyGlucoCare" Smartphone-Based Self-Management for Personalised Support of Women With Gestational Diabetes
- Plain-language title
- Testing a smartphone app to support women with gestational diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07372872, who can take part
- Record updated
- 22 May 2026